Sec Form 4 Filing - SUVRETTA CAPITAL MANAGEMENT, LLC @ Veradermics, Inc

Insider filing report for Changes in Beneficial Ownership

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Here is the list of insider trading transaction codes

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Expires:

November 30, 2011

Estimated average burden hours per response...

0.5

1. Name and Address of Reporting Person

SUVRETTA CAPITAL MANAGEMENT, LLC

2. Issuer Name and Ticker or Trading Symbol
Veradermics, Inc [ MANE]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X __ Director	X __ 10% Owner
_____ Officer (give title below)	_____ Other (specify below)

(Last)

(First)

(Middle)

540 MADISON AVENUE, 7TH FLOOR

3. Date of Earliest Transaction (MM/DD/YY)
02/04/2026

(Street)

NEW YORK, NY10022

4. If Amendment, Date Original Filed (MM/DD/YY)

6. Individual or Joint/Group Filing (Check Applicable Line)
_____ Form filed by One Reporting Person
__ X __ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

**Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned**
1.Title of Security (Instr. 3)	2. Transaction Date (MM/DD/YY)	2A. Deemed Execution Date, if any (MM/DD/YY)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Transaction Date (MM/DD/YY)	2A. Deemed Execution Date, if any (MM/DD/YY)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common stock, par value $0.00001 per share	02/04/2026		P		10,004 ^{( 2 )}	A	$ 34.25 ^{( 2 )}	3,525,462	I ^{( 1 )}	See footnotes ^{( 1 )} ^{( 2 )}
Common stock, par value $0.00001 per share	02/04/2026		P		10,676 ^{( 3 )}	A	$ 34.74 ^{( 3 )}	3,536,138	I ^{( 1 )}	See footnotes ^{( 1 )} ^{( 3 )}
Common stock, par value $0.00001 per share	02/04/2026		P		14,659 ^{( 4 )}	A	$ 36.27 ^{( 4 )}	3,550,797	I ^{( 1 )}	See footnotes ^{( 1 )} ^{( 4 )}
Common stock, par value $0.00001 per share	02/04/2026		P		53,344 ^{( 5 )}	A	$ 37.11 ^{( 5 )}	3,604,141	I ^{( 1 )}	See footnotes ^{( 1 )} ^{( 5 )}
Common stock, par value $0.00001 per share	02/04/2026		P		25,908 ^{( 6 )}	A	$ 38.09 ^{( 6 )}	3,630,049	I ^{( 1 )}	See footnotes ^{( 1 )} ^{( 6 )}
Common stock, par value $0.00001 per share	02/04/2026		P		18,489 ^{( 7 )}	A	$ 38.9 ^{( 7 )}	3,648,538	I ^{( 1 )}	See footnotes ^{( 1 )} ^{( 7 )}
Common stock, par value $0.00001 per share	02/04/2026		P		1,720 ^{( 8 )}	A	$ 34.25 ^{( 8 )}	372,579	I ^{( 1 )}	See footnotes ^{( 1 )} ^{( 8 )}
Common stock, par value $0.00001 per share	02/04/2026		P		1,835 ^{( 9 )}	A	$ 34.74 ^{( 9 )}	374,414	I ^{( 1 )}	See footnotes ^{( 1 )} ^{( 9 )}
Common stock, par value $0.00001 per share	02/04/2026		P		2,519 ^{( 10 )}	A	$ 36.27 ^{( 10 )}	376,933	I ^{( 1 )}	See footnotes ^{( 1 )} ^{( 10 )}
Common stock, par value $0.00001 per share	02/04/2026		P		9,168 ^{( 11 )}	A	$ 37.11 ^{( 11 )}	386,101	I ^{( 1 )}	See footnotes ^{( 1 )} ^{( 11 )}
Common stock, par value $0.00001 per share	02/04/2026		P		4,453 ^{( 12 )}	A	$ 38.09 ^{( 12 )}	390,554	I ^{( 1 )}	See footnotes ^{( 1 )} ^{( 12 )}
Common stock, par value $0.00001 per share	02/04/2026		P		3,178 ^{( 13 )}	A	$ 38.9 ^{( 13 )}	393,732	I ^{( 1 )}	See footnotes ^{( 1 )} ^{( 13 )}
Common stock, par value $0.00001 per share	02/05/2026		P		3,832 ^{( 14 )}	A	$ 36.07 ^{( 14 )}	397,564	I ^{( 1 )}	See footnotes ^{( 1 )} ^{( 14 )}
Common stock, par value $0.00001 per share	02/05/2026		P		19,199 ^{( 15 )}	A	$ 36.93 ^{( 15 )}	416,763	I ^{( 1 )}	See footnotes ^{( 1 )} ^{( 15 )}
Common stock, par value $0.00001 per share	02/05/2026		P		38,771 ^{( 16 )}	A	$ 37.63 ^{( 16 )}	455,534	I ^{( 1 )}	See footnotes ^{( 1 )} ^{( 16 )}
Common stock, par value $0.00001 per share	02/05/2026		P		17,835 ^{( 17 )}	A	$ 38.67 ^{( 17 )}	473,369	I ^{( 1 )}	See footnotes ^{( 1 )} ^{( 17 )}
Common stock, par value $0.00001 per share	02/05/2026		P		16,563 ^{( 18 )}	A	$ 39.8 ^{( 18 )}	489,932	I ^{( 1 )}	See footnotes ^{( 1 )} ^{( 18 )}
Common stock, par value $0.00001 per share	02/06/2026		P		11,183 ^{( 19 )}	A	$ 35.97 ^{( 19 )}	501,115	I ^{( 1 )}	See footnotes ^{( 1 )} ^{( 19 )}
Common stock, par value $0.00001 per share	02/06/2026		P		19,338 ^{( 20 )}	A	$ 36.55 ^{( 20 )}	520,453	I ^{( 1 )}	See footnotes ^{( 1 )} ^{( 20 )}

**Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned**
( *e.g.* , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (MM/DD/YY)	3A. Deemed Execution Date, if any (MM/DD/YY)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)		6. Date Exercisable and Expiration Date (MM/DD/YY)		7. Title and Amount of Underlying Securities (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

**Reporting Owners**
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
SUVRETTA CAPITAL MANAGEMENT, LLC 540 MADISON AVENUE 7TH FLOOR NEW YORK, NY10022	X	X
Cowen Aaron C/O SUVRETTA CAPITAL MANAGEMENT, LLC 540 MADISON AVENUE, 7TH FLOOR NEW YORK, NY10022		X
Averill Master Fund, Ltd. C/O SUVRETTA CAPITAL MANAGEMENT, LLC 540 MADISON AVENUE, 7TH FLOOR NEW YORK, NY10022	X	X
Averill Madison Master Fund, Ltd. C/O SUVRETTA CAPITAL MANAGEMENT, LLC 540 MADISON AVENUE, 7TH FLOOR NEW YORK, NY10022	X	X

**Signatures**
Suvretta Capital Management, LLC; By: /s/ Andrew Nathanson, General Counsel & Chief Compliance Officer		02/09/2026
Signature of Reporting Person		Date

Explanation of Responses:

( 1 )Notes are included on Exhibit 99.1.
( 2 )Notes are included on Exhibit 99.1.
( 3 )Notes are included on Exhibit 99.1.
( 4 )Notes are included on Exhibit 99.1.
( 5 )Notes are included on Exhibit 99.1.
( 6 )Notes are included on Exhibit 99.1.
( 7 )Notes are included on Exhibit 99.1.
( 8 )Notes are included on Exhibit 99.1.
( 9 )Notes are included on Exhibit 99.1.
( 10 )Notes are included on Exhibit 99.1.
( 11 )Notes are included on Exhibit 99.1.
( 12 )Notes are included on Exhibit 99.1.
( 13 )Notes are included on Exhibit 99.1.
( 14 )Notes are included on Exhibit 99.1.
( 15 )Notes are included on Exhibit 99.1.
( 16 )Notes are included on Exhibit 99.1.
( 17 )Notes are included on Exhibit 99.1.
( 18 )Notes are included on Exhibit 99.1.
( 19 )Notes are included on Exhibit 99.1.
( 20 )Notes are included on Exhibit 99.1.

Remarks:
Exhibit List: Exhibit 99.1 - Explanation of Responses Exhibit 99.2 - Joint Filer Information Exhibit 99.3 - Joint Filers' Signature

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Sec Form 4 Filing - SUVRETTA CAPITAL MANAGEMENT, LLC @ Veradermics, Inc - 2026-02-04